The interplay of nitric oxide and peroxynitrite with signal transduction pathways: Implications for disease

被引:42
作者
McAndrew, J
Patel, RP
Jo, HJ
Cornwell, T
Lincoln, T
Moellering, D
White, CR
Matalon, S
DarleyUsmar, V
机构
[1] UNIV ALABAMA, DIV MOL & CELLULAR PATHOL, BIRMINGHAM, AL 35294 USA
[2] UNIV ALABAMA, DEPT PATHOL, BIRMINGHAM, AL 35294 USA
[3] UNIV ALABAMA, DEPT MED, BIRMINGHAM, AL 35294 USA
[4] UNIV ALABAMA, DEPT ANESTHESIOL, BIRMINGHAM, AL 35294 USA
[5] UNIV ALABAMA, CTR FREE RAD BIOL, BIRMINGHAM, AL 35294 USA
关键词
D O I
10.1016/S0146-0005(97)80002-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Since the discovery that at least one form of endothelium derived relaxing factor is nitric oxide (NO), numerous studies have uncovered diverse roles for this free radical in a variety of physiological and pathophysiological processes. NO production, a process mediated by a family of enzymes termed NO synthases, has been detected in most cell types. Many of the effects of NO are thought to be mediated through its direct interaction with specific and defined cell signaling pathways. The nature of such interactions are highly dependent on the concentration of NO and cell type. Furthermore, specific NO derived reaction products, such as peroxynitrite, also have the potential to effect cell signal transduction events. As with NO, this can occur through diverse mechanisms and depends on concentration and cell type. It is perhaps not surprising that the reported effects of NO in different disease states are often conflicting. In this brief overview, a framework for placing these apparently disparate properties of NO will be described and will focus on the effects of NO and peroxynitrite on signaling pathways.
引用
收藏
页码:351 / 366
页数:16
相关论文
共 125 条
[31]   Redox regulation of NF-kappa B activation [J].
Flohe, L ;
Brigelius-Flohe, R ;
Saliou, C ;
Traber, MG ;
Packer, L .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (06) :1115-1126
[33]  
FRANCESCHI D, 1990, SURGERY, V108, P292
[34]  
FRANCIS SH, 1988, MOL PHARMACOL, V34, P506
[35]   CLINICAL-PHARMACOLOGY OF ORGANIC NITRATES [J].
FUNG, HL ;
SMITH, TW ;
GANZ, P ;
PARKER, JO ;
COHN, JN ;
PARKER, JD ;
GORLIN, R ;
MICHEL, T .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (08) :C9-C15
[36]  
Garvey EP, 1996, METHOD ENZYMOL, V268, P339
[37]   GENERATION OF REACTIVE OXYGEN METABOLITES BY PHAGOCYTOSING ENDOTHELIAL-CELLS [J].
GOROG, P ;
PEARSON, JD ;
KAKKAR, VV .
ATHEROSCLEROSIS, 1988, 72 (01) :19-27
[38]   THE ANTIOXIDANT EFFECT OF SPERMINE NONOATE IN HUMAN LOW-DENSITY-LIPOPROTEIN [J].
GOSS, SPA ;
HOGG, N ;
KALYANARAMAN, B .
CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (05) :800-806
[39]   PEROXYNITRITE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN LEADS TO RECOGNITION BY THE MACROPHAGE SCAVENGER RECEPTOR [J].
GRAHAM, A ;
HOGG, N ;
KALYANARAMAN, B ;
OLEARY, V ;
DARLEYUSMAR, V ;
MONCADA, S .
FEBS LETTERS, 1993, 330 (02) :181-185
[40]   Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B [J].
Griscavage, JM ;
Wilk, S ;
Ignarro, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3308-3312